Carleigh Kmetz carleigh.kmetz@abbvie.com Global Media: Mary Byun mary.byun@abbvie.com Investors: Liz Shea liz.shea@abbvie.com ...

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis Approval ...

For many, Nigeria’s economy may be growing on paper, but on the ground, cash is a rumour, trust is fragile, and survival has become its own kind of policy. This is the story of those who live inside ...

Have you ever wanted to write for the Drummer? Do you have an idea for an article or monthly column you would like to pitch? Bonus: do you have a good potluck dish or dessert you would be willing to ...